Enhanced in vivo monooxygenase activities of mammalian P450s in engineered yeast cells producing high levels of NADPH-P450 reductase and human cytochrome b5

This publication has 24 references indexed in Scilit:

• Optimization of yeast‐expressed human liver cytochrome P450 3A4 catalytic activities by coexpressing NADPH‐cytochrome P450 reductase and cytochrome b₅
  European Journal of Biochemistry, 1992
• Expression and characterization of a rabbit liver cytochrome P450 belonging to P450IIB subfamily with the aid of the baculovirus expression vector system
  Biochemical and Biophysical Research Communications, 1991
• Expression of human liver cytochrome P450 IIIA4 in yeast
  European Journal of Biochemistry, 1990
• Maximizing the expression of mammalian cytochrome P-450 monooxygenase activities in yeast cells
  Biochimie, 1990
• Disruption of the Saccharomyces Cerevlsiae gene for NADPH-cytochrome P450 reductase causes increased sensitivity to ketoconazole
  Biochemical and Biophysical Research Communications, 1989
• Genetically Engineered Modification of P450 Monooxygenases: Functional Analysis of the Amino-Terminal Hydrophobic Region and Hinge Region of the P450/Reductase Fused Enzyme
  DNA, 1988
• The complete nucleotide sequence of human liver cytochrome b5 mRNA
  Biochemical and Biophysical Research Communications, 1988
• Expression of Rat NADPH-Cytochrome P-450 Reductase cDNA inSaccharomyces cerevisiae
  DNA, 1986
• A positive selection for mutants lacking orotidine-5′-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance
  Molecular Genetics and Genomics, 1984
• Cytochrome b5 as electron donor to rabbit liver cytochrome P-450LM2 in reconstituted phospholipid vesicles
  Biochemical and Biophysical Research Communications, 1980